NovaGo Therapeutics
The startup develops human antibody therapeutics that block the Nogo-A receptor, which inhibits nerve growth, to promote nerve regeneration in patients with spinal cord injuries. This therapy aims to enhance functional recovery for individuals suffering from severe neurological disorders by facilitating nerve repair.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$11.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops human antibody therapeutics that block the Nogo-A receptor, which inhibits nerve growth, to promote nerve regeneration in patients with spinal cord injuries. This therapy aims to enhance functional recovery for individuals suffering from severe neurological disorders by facilitating nerve repair.